Timothy - UnitedHealth Group Independent Director

UNH Stock  USD 494.70  1.60  0.32%   

Director

Mr. Timothy P. Flynn is Independent Director of the Company. Mr. Flynn was the Chairman of KPMG International, a global professional services organization that provides audit, tax, and advisory services, from 2007 until his retirement in October 2011. From 2005 until 2010, he served as Chairman and from 2005 to 2008 as Chief Executive Officer of KPMG LLP in the U.S., the largest individual member firm of KPMG. Prior to serving as Chairman and CEO of KPMG LLP, Mr. Flynn was Vice Chairman, Audit and Risk Advisory Services, with operating responsibility for Audit, Risk Advisory and Financial Advisory Service practices. Mr. Flynn has served as a member of the board of directors of JPMorgan Chase Co. since 2012, as a member of the Board of Directors of Alcoa since November 2016 and as a member of the board of directors of WalMart Stores, Inc. since 2012. He previously served as a member of the board of directors of The Chubb Corporation from September 2013 until its acquisition in January 2016 and as the Advisory Chair for the Americas at British Telecom, a role that he held from April 2014 to September 2016. He was a director of the International Integrated Reporting Council since September 2015, while he previously served as a trustee of the Financial Accounting Standards Board, as a member of the World Economic Forum International Business Council, and was a founding member of The Prince of Wales International Integrated Reporting Committee. since 2017.
Age 58
Tenure 7 years
Address UnitedHealth Group Center, Minnetonka, MN, United States, 55343
Phone952 936 1300
Webhttps://www.unitedhealthgroup.com

UnitedHealth Group Management Efficiency

The company has Return on Asset of 0.0779 % which means that on every $100 spent on assets, it made $0.0779 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2499 %, implying that it generated $0.2499 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities. The UnitedHealth Group's current Return On Equity is estimated to increase to 0.26, while Return On Capital Employed is projected to decrease to 0.15. As of now, UnitedHealth Group's Total Current Assets are increasing as compared to previous years. The UnitedHealth Group's current Intangible Assets is estimated to increase to about 16 B, while Non Currrent Assets Other are projected to decrease to under 10.9 B.
The company has 67.44 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

DIRECTOR Age

Siddhartha SankaranOscar Health
46
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. Unitedhealth operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 350000 people. UnitedHealth Group Incorporated (UNH) is traded on New York Stock Exchange in USA. It is located in UnitedHealth Group Center, Minnetonka, MN, United States, 55343 and employs 440,000 people. UnitedHealth Group is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

UnitedHealth Group Leadership Team

Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gail Wilensky, Independent Director
Timothy, Independent Director
Richard Burke, Independent Chairman of the Board
Valerie Rice, Independent Director
Andrew Witty, Group President, Chief Executive Officer, Executive Vice President, Director
Terry Clark, Executive Officer
Sir Witty, CEO Director
Stephen Hemsley, Non-Executive Chairman of the Board
John Rex, Chief Financial Officer, Executive Vice President
Dirk McMahon, President and Chief Operating Officer; Chief Executive Officer of UnitedHealthcare
DEllen Wilson, Executive Vice President - Human Capital
Steven Nelson, Executive Vice President CEO of UnitedHealthcare
Zachary Sopcak, Senior Relations
William McNabb, Independent Director
John Noseworthy, Independent Director
Larry Renfro, Vice Chairman and CEO of Optum
Robert Darretta, Independent Director
Jennifer Smoter, Senior Officer
William Ballard, Independent Director
Glenn Renwick, Independent Director
Rupert Bondy, Ex Officer
Sandeep Dadlani, Executive Officer
Michele Hooper, Lead Independent Director
Timothy Flynn, Independent Director
Thomas Roos, Senior Vice President, Chief Accounting Officer
Rodger Lawson, Independent Director
Frances Jacobs, IR Contact Officer
Matthew Friedrich, Executive Vice President Chief Legal Officer
Kenneth Shine, Independent Director
Edson Bueno, Director
D Wilson, Executive Vice President - Human Capital
F McNabb, Independent Director
Paul Garcia, Independent Director
Marianne Short, Executive Vice President, Chief Legal Officer
David Wichmann, Chief Executive Officer, Director
Patricia Lewis, Chief Human Resource Officer, Executive Vice President
Brian Thompson, Executive UnitedHealthcare
James Barry, Director Pennsylvania

UnitedHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.16
Dividend Share
7.29
Earnings Share
23.87
Revenue Per Share
400.455
Quarterly Revenue Growth
0.141
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.